Last Price$64.9(1.2%)
Market Cap$82.3B
4.2%
Peers median - 9.5%
1.7%
Peers median - 2.3%
109.5%
Peers median - 18.6%
3.7%
Peers median - 8.4%
Competing with CVS
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$82.3B | 5.1 | $208.2 220.8% undervalued | (9.3%) | $372.8B | $6,326.0M | 4.2% | 1.7% | 13.8% | 3.7% | 109.5% | |
$436.0B | 5.9 | $1,047.3 124.2% undervalued | (1.6%) | $398.3B | $20.7B | 8.4% | 5.2% | 21.9% | 28.1% | 1.5% | |
$90.7B | 6.7 | $1,001.8 153.3% undervalued | (20.5%) | $176.8B | $4,552.0M | 3.2% | 2.6% | 43.4% | 161.3% | 4.9% | |
$87.2B | 5.8 | $942.9 202.7% undervalued | (6.0%) | $245.3B | $8,957.0M | 25.7% | 3.7% | 48.9% | 4.9% | 77.5% | |
$31.5B | 6.1 | $797.8 205.0% undervalued | (23.7%) | $117.8B | $2,391.0M | 10.7% | 2.0% | 91.9% | 58.6% | 71.3% | |
$29.1B | 5.4 | $1,406.9 2,301.3% undervalued | (25.2%) | $163.1B | ($490.0M) | 5.9% | (0.3%) | 13.1% | 12.0% | 69.9% | |
$17.3B | 6.3 | $414.9 37.0% undervalued | (21.7%) | $40.6B | $544.0M | 19.2% | 1.3% | 34.7% | 33.0% | 69.4% | |
$3,703.3M | 6.1 | $23.7 57.0% undervalued | (1.7%) | $9,177.6M | $950.3M | 56.6% | 10.4% | 100.0% | (15.2%) | 29.5% | |
$3,104.9M | 5.4 | $8.2 47.0% overvalued | 187.4% | $2,703.6M | ($6,648.0K) | 48.3% | (0.2%) | 33.7% | (41.1%) | 7.8% | |
$1,871.6M | 5.2 | $2.0 45.3% overvalued | 330.8% | $1,370.6M | $128.3M | (32.4%) | 9.4% | 53.9% | 1.2% | 0.0% | |
$65.5M | 5.0 | $46.2 463.3% undervalued | (85.9%) | $1,616.6M | ($2,834.8M) | (71.1%) | (175.4%) | 7.8% | (63.3%) | (145.5%) |
Compare CVS Valuation Multiples with Peers
LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
General
Valuation Multiple
Financial metrics
Company name
EV/Revenue
Revenue growth
EBITDA margin
Net Income margin
CVS Health CorporationCVS
0.4x
4.2%
(43.6%)
1.2%
Median Peer Set
0.4x
8.7%
(2.4%)
1.5%
Alignment Healthcare, Inc.ALHC
1.0x
27.2%
(4.8%)
(8.1%)
Bright Health Group, Inc.BHG
N/A
(51.9%)
86.2%
(103.4%)
Cigna CorporationCI
0.5x
8.4%
(18.9%)
2.6%
Clover Health Investments, Corp.CLOV
1.2x
(41.5%)
(31.3%)
(10.5%)
Centene CorporationCNC
0.2x
5.9%
27.4%
2.0%
Elevance Health Inc.ELV
0.5x
3.2%
(0.0%)
3.4%
Humana Inc.HUM
0.2x
10.7%
(50.1%)
1.0%
Molina Healthcare, Inc.MOH
0.4x
19.3%
9.2%
2.9%
Oscar Health, Inc.OSCR
0.2x
56.5%
N/A
0.3%
UnitedHealth Group IncorporatedUNH
1.0x
8.9%
(35.7%)
3.6%
Compare CVS Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does CVS Health Corporation (CVS) revenue growth compare to peers and the industry?
CVS Health Corporation (CVS) revenue growth is 4.2%, compared to the peers' median of 9.5%.
2. How does CVS Health Corporation (CVS) Free Cash Flow (FCF) margin compare to peers and the industry?
CVS Health Corporation (CVS) FCF margin is 1.7%, compared to the peers' median of 2.3%.
3. How does CVS Health Corporation (CVS) Total Debt to Equity ratio compare to peers and the industry?
CVS Health Corporation (CVS) Total Debt to Equity ratio is 109.5%, compared to the peers' median of 18.6%.
4. How does CVS Health Corporation (CVS) ROIC (Return on Invested Capital) compare to peers and the industry?
CVS Health Corporation (CVS) ROIC is 3.7%, compared to the peers' median of 8.4%.